Healthy liver emerging from a dark landscape symbolizing the hope of liver transplantation for ACLF.

Liver Transplants for ACLF: A Lifeline for Failing Livers?

Lena Voss monogram
Lena Voss in Health & Wellness November 2026 • 4 min read.

"Discover how liver transplantation offers hope for patients with acute-on-chronic liver failure (ACLF), improving survival rates and quality of life."


Acute-on-chronic liver failure (ACLF) represents a critical juncture in liver disease, characterized by a rapid deterioration of liver function in individuals with pre-existing chronic liver conditions. This sudden decline often leads to organ failure, making ACLF patients significantly more vulnerable than those with stable cirrhosis. The incidence of organ failure in ACLF is alarmingly high, necessitating intensive medical intervention.

Liver transplantation (LT) has emerged as a vital treatment option for ACLF, offering a chance at improved survival, especially when performed before the development of multi-organ failure. However, identifying suitable candidates for transplantation remains a challenge. Current scoring systems lack the precision needed to accurately predict which patients will recover with medical management alone and which require urgent transplant.

This article delves into the role of liver transplantation in ACLF, exploring patient selection criteria, survival outcomes, and the latest research shaping transplant strategies. We aim to provide a comprehensive overview for patients, families, and healthcare professionals navigating the complexities of ACLF and liver transplantation.

AI Search Multiple angles on this topic

Defining ACLF

Acute-on-chronic liver failure (ACLF) emerged as a distinct lethal syndrome caused by acute exacerbation of underlying chronic liver disease. It is characterized by acute decompensation, organ failure, and high short-term mortality, and is described as one of the three leading causes of death among patients with chronic liver diseases. Unlike ordinary cirrhosis, ACLF carries a remarkably worse prognosis because organ failure can develop despite medical care. The 2017 review reported that timely liver transplantation before the development of multiorgan failure was associated with good survival rates.

What is ACLF and Why Does It Require Special Attention?

Healthy liver emerging from a dark landscape symbolizing the hope of liver transplantation for ACLF.

ACLF differs significantly from decompensated cirrhosis. While both conditions involve liver dysfunction, ACLF is triggered by an acute event that accelerates liver damage. This acute insult can range from viral hepatitis and bacterial infections to alcohol abuse or surgical complications. The rapid deterioration associated with ACLF leads to a high risk of organ failure and short-term mortality.

The key characteristics of ACLF include hepatic and extrahepatic organ failures, such as kidney dysfunction, respiratory distress, and brain complications (encephalopathy). Although ACLF is severe, it also presents a window of opportunity for intervention. Some patients may recover to their pre-ACLF state with appropriate treatment. However, without improvement, the prognosis is poor, and liver transplantation becomes a critical consideration.

  • The Asian Pacific Association for the Study of the Liver (APASL): Defines ACLF as acute hepatic insult with jaundice and coagulopathy, complicated by ascites or encephalopathy.
  • The European Association for the Study of the Liver (EASL): Focuses on acute decompensation, organ failure, and high mortality rates in cirrhotic patients.
  • The World Gastroenterology Organisation: Includes non-cirrhotic chronic liver disease as an underlying factor in ACLF.
AI Search Multiple angles on this topic

Transplant Prioritisation Evolves

Recent research continues to describe ACLF as acute deterioration of chronic liver disease accompanied by systemic inflammation, organ failures, and high short-term mortality. The Lancet Regional Health – Europe reported that an ACLF prioritisation tier has been adopted within the United Kingdom national liver graft allocation policy. A 2024 Lancet review states that few effective therapeutic options exist and that liver transplantation is often the only life-saving treatment with acceptable outcomes in carefully selected patients. Newer critical-care guidance emphasizes serial clinical trajectory rather than relying on a single physiological measurement when assessing transplant decisions.

Limits and Risks

Not every intervention used in critically ill ACLF patients has demonstrated a survival benefit. A 2025 review argues that devices should not enter routine clinical practice until their roles as bridges to transplantation or as treatments improving transplant-free survival are better defined. Long-term follow-up research reports that ACLF predicts high post-transplant mortality, with lethal infections implicated early and late after transplantation. At the same time, a 2024 review reports one-year post-transplant survival of 80% to 90% for ACLF, indicating that outcomes can be favorable but remain dependent on careful selection and clinical circumstances.

Survival After Transplant

A systematic review with meta-analysis found lower post-transplant survival among patients with ACLF than among comparison patients at every reported time point. Survival was 96.2% versus 98.1% at 30 days, 92.6% versus 96.2% at 90 days, 89.9% versus 94.4% at six months, 86.0% versus 91.9% at one year, and 66.9% versus 80.7% at five years. The differences were statistically significant for all listed intervals. Despite this disadvantage, other reviewed sources describe transplantation as a life-saving or potentially curative treatment for severe ACLF.

The course of ACLF can vary significantly among individuals. Some patients experience rapid deterioration, while others progress more slowly. Regular monitoring and assessment are crucial to identify those who will benefit from early liver transplantation.

The Future of Liver Transplantation in ACLF

Liver transplantation offers a crucial lifeline for carefully selected patients with ACLF. Ongoing research and refinements in patient selection criteria promise to further improve outcomes and expand access to this life-saving therapy. By staying informed and advocating for timely intervention, we can help ensure that more individuals with ACLF receive the care they need to thrive.

AI Search Multiple angles on this topic

Access and Evidence Gaps

ACLF remains a complex condition involving deteriorating liver and kidney function together with other organ failure in patients with chronic liver disease. Although disease-specific therapies are being researched, the reviewed source states that more studies are needed to establish their safety and efficacy. Earlier transplantation appears effective for selected patients, but future management strategies must also address access to liver transplantation. These challenges make allocation and timely referral central parts of ACLF care.

A Narrow Window for Survival

Patients with ACLF can face high mortality over a short period. A 2022 study aimed to compare the prognosis of transplanted ACLF patients with that of nontransplanted ACLF patients and decompensated cirrhosis recipients. The reviewed material also reports that survival after transplantation ranges between 80% and 90% for ACLF, compared with 90% to 95% for acute liver failure. These outcomes underscore both the potential life-saving value of transplantation and the seriousness of the condition before transplant.

How ACLF transplant cohorts differ across reported outcomes

A separate comparison found higher serum creatinine in recipients transplanted in the context of ACLF than in the comparison group: 2.27 versus 0.98.[1]

Together, these cohorts place transplant outcomes in context: transplantation can be associated with substantial short-term survival, but the comparison group and the severity of illness materially affect the result.[1] [2]

What remains uncertain about nontransplant therapies

  • Therapies aimed at liver regeneration and inflammatory pathways have produced variable results, with limited generalizability across patient groups.[3]
  • The evidence does not establish whether high-cost devices can reliably serve as bridges to transplantation or improve survival without transplantation.[3]
  • Observed differences between interventions may reflect population or disease-cause factors, and patients with severe ACLF may be too advanced for some interventions to work.[3]

Questions about treatment comparisons

What can affect interpretation of registry-based transplant results?

Possible issues include misclassification of ACLF severity, incomplete information about why mechanical ventilation was used, and inability to account for alcohol relapse as a cause of mortality after transplantation.[4]

Terms used in ACLF transplant research

ACLF
A severe form of acutely decompensated cirrhosis characterized by organ-system failure and a high risk of short-term mortality.[5]
High-grade ACLF
ACLF classified through dynamic assessment of associated organ failures during days 3 to 7.[3]

Sources

  1. Outcomes of Liver Transplant Recipients With Acute-on-Chronic Liver Failure Based on EASL-CLIF Consortium Definition: A Single-center Study (journals.lww.com, 2020)
  2. Liver transplantation for critically ill patients with acute on chronic liver failure: a prospective national programme of waitlist prioritisation - The Lancet Regional Health – Europe (www.thelancet.com, 2024)
  3. From Critical Care to Transplant: Enhancing Outcomes in Acute-on-Chronic Liver Failure (link.springer.com)
  4. Effect of the clinical course of acute-on-chronic liver failure prior to liver transplantation on post-transplant survival (pmc.ncbi.nlm.nih.gov, 2020)
  5. Clinical Practice Guidelines EASL Clinical Practice Guidelines on acute-on-chronic liver failure ☆ (www.sciencedirect.com, 2023)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

What exactly is acute-on-chronic liver failure (ACLF), and why is it so serious?

Acute-on-chronic liver failure (ACLF) is a condition where someone with an existing chronic liver disease experiences a sudden and rapid decline in liver function. This differs from decompensated cirrhosis, as it involves an acute event that accelerates liver damage, increasing the risk of organ failure and mortality. The specific cause could be viral hepatitis, bacterial infections, alcohol abuse or surgical complications. It demands immediate attention because of the high risk of organ failure which could include kidney dysfunction, respiratory distress or brain complications. Without timely intervention, especially if there is no improvement, liver transplantation becomes a necessity.

2

Why is liver transplantation (LT) considered for patients with acute-on-chronic liver failure (ACLF)?

Liver transplantation (LT) is important for individuals with acute-on-chronic liver failure (ACLF) because it offers a chance at improved survival, especially when performed before the development of multi-organ failure. When the liver is failing, other organs can also be affected such as the kidneys. LT is a treatment option that can greatly improve someone's quality of life. Selecting the best candidates remains a challenge.

3

How do different medical organizations define acute-on-chronic liver failure (ACLF)?

Several organizations have slightly different definitions of acute-on-chronic liver failure (ACLF). The Asian Pacific Association for the Study of the Liver (APASL) defines ACLF as an acute hepatic insult with jaundice and coagulopathy, complicated by ascites or encephalopathy. The European Association for the Study of the Liver (EASL) focuses on acute decompensation, organ failure, and high mortality rates in cirrhotic patients. The World Gastroenterology Organisation includes non-cirrhotic chronic liver disease as an underlying factor in ACLF. The differences in definitions mean the criteria used to determine whether liver transplantation is necessary can vary.

4

What are the survival rates for patients with acute-on-chronic liver failure (ACLF) who undergo a liver transplant (LT)?

The survival rates of patients with acute-on-chronic liver failure (ACLF) following a liver transplant (LT) depend on several factors, the most important of which is intervening before multi-organ failure develops. Regular monitoring and assessment are crucial to identify those who will benefit from early liver transplantation. The key is to perform the transplant before the patient's condition deteriorates beyond a certain point, as outcomes are significantly better when the transplant is done preemptively.

5

What is the focus of current research in the areas of acute-on-chronic liver failure (ACLF) and liver transplantation (LT)?

Ongoing research in acute-on-chronic liver failure (ACLF) and liver transplantation (LT) is focused on refining patient selection criteria to improve outcomes and expand access to this life-saving therapy. This includes improving scoring systems to predict which patients will benefit most from liver transplantation, and which may recover with medical management alone. Additionally, research aims to optimize transplant procedures and post-transplant care to enhance survival rates and quality of life for ACLF patients.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.